Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Intestinal tumor progression is promoted by decreased apoptosis and dysregulated Wnt signaling in Ceacam1-/- mice.

Leung N, Turbide C, Balachandra B, Marcus V, Beauchemin N.

Oncogene. 2008 Aug 21;27(36):4943-53. doi: 10.1038/onc.2008.136. Epub 2008 May 5.

PMID:
18454175
2.

SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms.

Nagaishi T, Pao L, Lin SH, Iijima H, Kaser A, Qiao SW, Chen Z, Glickman J, Najjar SM, Nakajima A, Neel BG, Blumberg RS.

Immunity. 2006 Nov;25(5):769-81. Epub 2006 Nov 2.

3.

CEACAM1: contact-dependent control of immunity.

Gray-Owen SD, Blumberg RS.

Nat Rev Immunol. 2006 Jun;6(6):433-46. Review.

PMID:
16724098
4.

Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1.

Park SY, Cho YR, Kim HJ, Hong EG, Higashimori T, Lee SJ, Goldberg IJ, Shulman GI, Najjar SM, Kim JK.

Am J Physiol Endocrinol Metab. 2006 Sep;291(3):E517-24. Epub 2006 Apr 25.

5.

Pathophysiology of graft-versus-host disease.

Ferrara JL, Reddy P.

Semin Hematol. 2006 Jan;43(1):3-10. Review.

PMID:
16412784
6.

Absence of beta7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestine.

Waldman E, Lu SX, Hubbard VM, Kochman AA, Eng JM, Terwey TH, Muriglan SJ, Kim TD, Heller G, Murphy GF, Liu C, Alpdogan O, van den Brink MR.

Blood. 2006 Feb 15;107(4):1703-11. Epub 2005 Nov 15.

7.

L-selectin and beta7 integrin on donor CD4 T cells are required for the early migration to host mesenteric lymph nodes and acute colitis of graft-versus-host disease.

Dutt S, Ermann J, Tseng D, Liu YP, George TI, Fathman CG, Strober S.

Blood. 2005 Dec 1;106(12):4009-15. Epub 2005 Aug 16.

8.

In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets.

Beilhack A, Schulz S, Baker J, Beilhack GF, Wieland CB, Herman EI, Baker EM, Cao YA, Contag CH, Negrin RS.

Blood. 2005 Aug 1;106(3):1113-22. Epub 2005 Apr 26.

9.

The human tumor suppressor CEACAM1 modulates apoptosis and is implicated in early colorectal tumorigenesis.

Nittka S, Günther J, Ebisch C, Erbersdobler A, Neumaier M.

Oncogene. 2004 Dec 16;23(58):9306-13.

PMID:
15568039
10.

The tumour suppressor gene CEACAM1 is completely but reversibly downregulated in renal cell carcinoma.

Kammerer R, Riesenberg R, Weiler C, Lohrmann J, Schleypen J, Zimmermann W.

J Pathol. 2004 Nov;204(3):258-67.

PMID:
15476270
11.

CEACAM1 modulates epidermal growth factor receptor--mediated cell proliferation.

Abou-Rjaily GA, Lee SJ, May D, Al-Share QY, Deangelis AM, Ruch RJ, Neumaier M, Kalthoff H, Lin SH, Najjar SM.

J Clin Invest. 2004 Oct;114(7):944-52.

12.

The critical role of residues 43R and 44Q of carcinoembryonic antigen cell adhesion molecules-1 in the protection from killing by human NK cells.

Markel G, Gruda R, Achdout H, Katz G, Nechama M, Blumberg RS, Kammerer R, Zimmermann W, Mandelboim O.

J Immunol. 2004 Sep 15;173(6):3732-9.

13.

Ceacam1a-/- mice are completely resistant to infection by murine coronavirus mouse hepatitis virus A59.

Hemmila E, Turbide C, Olson M, Jothy S, Holmes KV, Beauchemin N.

J Virol. 2004 Sep;78(18):10156-65.

14.

Biological function of the soluble CEACAM1 protein and implications in TAP2-deficient patients.

Markel G, Achdout H, Katz G, Ling KL, Salio M, Gruda R, Gazit R, Mizrahi S, Hanna J, Gonen-Gross T, Arnon TI, Lieberman N, Stren N, Nachmias B, Blumberg RS, Steuer G, Blau H, Cerundolo V, Mussaffi H, Mandelboim O.

Eur J Immunol. 2004 Aug;34(8):2138-48.

15.

Specific regulation of T helper cell 1-mediated murine colitis by CEACAM1.

Iijima H, Neurath MF, Nagaishi T, Glickman JN, Nieuwenhuis EE, Nakajima A, Chen D, Fuss IJ, Utku N, Lewicki DN, Becker C, Gallagher TM, Holmes KV, Blumberg RS.

J Exp Med. 2004 Feb 16;199(4):471-82.

16.

Pathophysiology of acute graft-versus-host disease.

Reddy P.

Hematol Oncol. 2003 Dec;21(4):149-61. Review.

17.

The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients.

Markel G, Mussaffi H, Ling KL, Salio M, Gadola S, Steuer G, Blau H, Achdout H, de Miguel M, Gonen-Gross T, Hanna J, Arnon TI, Qimron U, Volovitz I, Eisenbach L, Blumberg RS, Porgador A, Cerundolo V, Mandelboim O.

Blood. 2004 Mar 1;103(5):1770-8. Epub 2003 Nov 6. Erratum in: Blood. 2015 Mar 19;125(12):2006.

18.

LPAM (alpha 4 beta 7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease.

Petrovic A, Alpdogan O, Willis LM, Eng JM, Greenberg AS, Kappel BJ, Liu C, Murphy GJ, Heller G, van den Brink MR.

Blood. 2004 Feb 15;103(4):1542-7. Epub 2003 Oct 16.

19.

Immunobiology of acute graft-versus-host disease.

Reddy P, Ferrara JL.

Blood Rev. 2003 Dec;17(4):187-94. Review.

PMID:
14556773
20.

Expression of CEACAM1 in adenocarcinoma of the lung: a factor of independent prognostic significance.

Laack E, Nikbakht H, Peters A, Kugler C, Jasiewicz Y, Edler L, Brümmer J, Schumacher U, Hossfeld DK.

J Clin Oncol. 2002 Nov 1;20(21):4279-84.

PMID:
12409325

Supplemental Content

Support Center